Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group

MLA

H, Akaza, et al. “Long-Term Clinical Study on Luteinising Hormone-Releasing Hormone Agonist Depot Formulation in the Treatment of Stage D Prostatic Cancer. The TAP-144-SR Study Group.” Japanese Journal of Clinical Oncology, vol. 22, no. 3, June 1992. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e6e90ea3e6598d990375b2caa8d87f05&authtype=sso&custid=ns315887.

APA

H, A., M, U., K, K., T, K., Y, A., & T, N. (1992). Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group. Japanese Journal of Clinical Oncology, 22(3).

Chicago

H, Akaza, Usami M, Koiso K, Kotake T, Aso Y, and Niijima T. 1992. “Long-Term Clinical Study on Luteinising Hormone-Releasing Hormone Agonist Depot Formulation in the Treatment of Stage D Prostatic Cancer. The TAP-144-SR Study Group.” Japanese Journal of Clinical Oncology 22 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e6e90ea3e6598d990375b2caa8d87f05&authtype=sso&custid=ns315887.